SEC Form 4 · accession 0001562180-18-000368
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa D Earnhardt
Officer — President and CEO · Director
Period of report
Jan 17, 2018
Accepted (ET)
Jan 19, 2018 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 17, 2018 | A | 25,500 | $0.00 | A | 495,849 | D | |
| Common StockF3 | Jan 18, 2018 | S | 11,166 | $33.4672 | D | 484,683 | D | |
| Common StockF4 | holding | — | — | — | 26,182 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F5 | $33.95 | Jan 17, 2018 | A | 119,000 | A | — | Jan 16, 2028 | Common Stock | 119,000 | 119,000 | D |
Explanation of responses
- F1Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in equal annual installments over three years commencing on January 1, 2018.
- F2The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.80, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F4Shares in the name of Lisa Damkroger Earnhardt C/F Jack L. Earnhardt UTMA/CA Until Age 25 for the benefit of Reporting Person's son. Reporting Person disclaims beneficial ownership of these shares.
- F51/8th of the shares subject to the option vest on July 1, 2018 and 1/48th of the total shares subject to the option vest monthly thereafter over 42 months.